Donald E. Mosier

Q: What Schools Are Affiliated With Donald E. Mosier

Donald E. Mosier is affiliated with the following schools: University of Amsterdam, California Institute of Technology, University of Chicago, Case Western Reserve University

Donald E. Mosier's AcademicInfluence.com Rankings

Donald E. Mosier

Biology

#9390

World Rank

#12591

Historical Rank

Immunology

#561

World Rank

#580

Historical Rank

biology Degrees

Download Badge

Biology

Donald E. Mosier's Degrees

PhD Immunology University of California, San Diego
Doctorate Medicine University of California, San Diego

Why Is Donald E. Mosier Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Donald E. Mosier's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Transfer of a functional human immune system to mice with severe combined immunodeficiency (1988) (1240)
Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. (1999) (661)
A Requirement for Two Cell Types for Antibody Formation in vitro (1967) (587)
Prevention of Vaginal SHIV Transmission in Rhesus Macaques Through Inhibition of CCR5 (2004) (312)
Human immunodeficiency virus infection of human-PBL-SCID mice. (1991) (283)
Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo. (1999) (266)
Biology of CCR5 and its role in HIV infection and treatment. (2006) (265)
Thymus-independent antigens: complexity of B-lymphocyte activation revealed. (1982) (249)
A THREE-CELL INTERACTION REQUIRED FOR THE INDUCTION OF THE PRIMARY IMMUNE RESPONSE in vitro. (1968) (235)
Ontogeny of mouse lymphocyte function. II. Development of the ability to produce antibody is modulated by T lymphocytes (1975) (210)
Rapid loss of CD4+ T cells in human-PBL-SCID mice by noncytopathic HIV isolates. (1993) (205)
Highly Potent RANTES Analogues either Prevent CCR5-Using Human Immunodeficiency Virus Type 1 Infection In Vivo or Rapidly Select for CXCR4-Using Variants (1999) (197)
Graft-versus-host disease after intrauterine and exchange transfusions for hemolytic disease of the newborn. (1974) (187)
Human Immunodeficiency Virus Type 1 Coreceptor Switching: V1/V2 Gain-of-Fitness Mutations Compensate for V3 Loss-of-Fitness Mutations (2006) (179)
Activation of mouse lymphocytes by anti-immunoglobulin. I. Parameters of the proliferative response (1978) (177)
Inhibition of RNA polymerase II transcription in human cells by synthetic DNA-binding ligands. (1998) (174)
Surface Immunoglobulin D as a Functional Receptor for a Subclass of B Lymphocytes (1977) (170)
CELL INTERACTIONS IN THE PRIMARY IMMUNE RESPONSE IN VITRO: A REQUIREMENT FOR SPECIFIC CELL CLUSTERS (1969) (167)
The ontogeny of thymic independent antibody responses in vitro in normal mice and mice with an X-linked B cell defect. (1977) (167)
Medicinal chemistry applied to a synthetic protein: development of highly potent HIV entry inhibitors. (2004) (163)
Protection against HIV‐1 infection in hu‐PBL-SCID mice by passive immunization with a neutralizing human monoclonal antibody against the gp120 CD4‐binding site (1995) (159)
Whither or Wither Microbicides? (2008) (139)
Intrinsic Obstacles to Human Immunodeficiency Virus Type 1 Coreceptor Switching (2004) (138)
Highly potent, fully recombinant anti-HIV chemokines: Reengineering a low-cost microbicide (2008) (137)
T‐independent responses in B cell‐defective CBA/N mice to Brucella abortus and to trinitrophenyl (TNP) conjugates of Brucella abortus (1978) (135)
CELLULAR REQUIREMENTS FOR THE PRIMARY IN VITRO ANTIBODY RESPONSE TO DNP-FICOLL (1974) (133)
Fitness Epistasis and Constraints on Adaptation in a Human Immunodeficiency Virus Type 1 Protein Region (2010) (128)
hu‐PBL‐SCID Mice: A Model for Human Immune Function, AIDS, and Lymphomagenesis (1991) (125)
In vitro responses of CBA/N mice: spleen cells of mice with an X-linked defect that precludes immune responses to several thymus-independent antigens can respond to TNP-lipopolysaccharide. (1976) (110)
Activation of mouse lymphocytes by anti-immunoglobulin. II. A thymus- independent response by a mature subset of B lymphocytes (1978) (108)
Pneumococcal polysaccharides induce antibody formation by human B lymphocytes in vitro. (1985) (100)
Two Mechanisms for Human Immunodeficiency Virus Type 1 Inhibition by N-Terminal Modifications of RANTES (2003) (95)
Macrophage-tropic HIV: critical for AIDS pathogenesis? (1994) (95)
Absence of an antigen‐specific helper T cell required for the expression of the Tn 15 idiotype in mice treated with anti‐μ antibody (1980) (95)
Evolutionary genetics: CCR5 mutation and plague protection (2004) (93)
Adoptive transfer of human lymphoid cells to severely immunodeficient mice: models for normal human immune function, autoimmunity, lymphomagenesis, and AIDS. (1991) (90)
Macrophage requirement for the in vitro response to TNP Ficoll: a thymic independent antigen. (1976) (89)
Inability of mice with a defect in B-lymphocyte maturation to respond to phosphorycholine on immunogenic carriers (1977) (85)
CCR5 promoter polymorphism determines macrophage CCR5 density and magnitude of HIV-1 propagation in vitro. (2003) (84)
Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160. (1993) (82)
Autoantibody production by severe combined immunodeficient mice reconstituted with synovial cells from rheumatoid arthritis patients (1990) (80)
Induction of B lymphocyte proliferation by monoclonal anti-Lyb 2 antibody. (1983) (78)
Animal models for retrovirus-induced immunodeficiency disease. (1986) (77)
FUNCTIONAL MATURATION OF THYMIC LYMPHOCYTE POPULATIONS IN VITRO (1972) (77)
Topically applied recombinant chemokine analogues fully protect macaques from vaginal simian-human immunodeficiency virus challenge. (2009) (76)
Anti-idiotype induced regulation of helper cell function for the response to phosphorylcholine in adult BALB/c mice (1978) (76)
HIV-1 subtype A envelope variants from early in infection have variable sensitivity to neutralization and to inhibitors of viral entry (2007) (76)
Heterogeneity among Epstein-Barr virus-seropositive donors in the generation of immunoblastic B-cell lymphomas in SCID mice receiving human peripheral blood leukocyte grafts. (1992) (75)
Ontogeny of mouse lymphocyte function. I. Paradoxical elevation of reactivity to allogeneic cells and phytohemagglutinin in BALB-c fetal thymocytes. (1974) (74)
Homozygous scid/scid;beige/beige mice have low levels of spontaneous or neonatal T cell-induced B cell generation (1993) (73)
The KSHV/HHV8-infected BCBL-1 lymphoma line causes tumors in SCID mice but fails to transmit virus to a human peripheral blood mononuclear cell graft. (1997) (70)
Cell-cell interactions in antibody production. (1972) (65)
THE RATE OF DIVISION OF ANTIBODY-FORMING CELLS DURING THE EARLY PRIMARY IMMUNE RESPONSE (1968) (65)
Functional maturation of mouse thymic lymphocytes (1971) (64)
Primary in vitro antibody responses by purified murine B lymphocytes in serum-free defined medium. (1981) (62)
Role of a nonimmunoglobulin cell surface determinant in the activation of B lymphocytes by thymus-independent antigens (1979) (58)
Primary Infection by a Human Immunodeficiency Virus with Atypical Coreceptor Tropism (2011) (57)
The antiviral activity of HIV-specific CD8+ CTL clones is limited by elimination due to encounter with HIV-infected targets. (1999) (57)
Lyb-7, a new B cell alloantigen controlled by genes linked to the IgCH locus. (1979) (57)
The role of surface IgD in the response to thymic-independent antigens (1977) (57)
In vitro studies of the genetically determined unresponsiveness to thymus-independent antigens in CBA/N mice. (1976) (57)
How HIV changes its tropism: evolution and adaptation? (2008) (56)
Formation of antibody in the newborn mouse: study of T-cell-independent antibody response. (1977) (56)
CD4+ cell turnover (1995) (52)
Cellular Deficit in Thymectomized Mice (1970) (51)
On the SCIDs? (1989) (51)
Common and idiosyncratic patterns of cytokine gene expression by Epstein-Barr virus transformed human B cell lines. (1997) (51)
Donor- and Ligand-Dependent Differences in C-C Chemokine Receptor 5 Reexpression (2001) (51)
Studies of HIV infection and the development of Epstein-Barr virus-related B cell lymphomas following transfer of human lymphocytes to mice with severe combined immunodeficiency. (1989) (51)
Differential Epstein-Barr virus gene expression in B-cell subsets recovered from lymphomas in SCID mice after transplantation of human peripheral blood lymphocytes (1995) (50)
Apoptosis induced by HIV infection in H9 T cells is blocked by ICE-family protease inhibition but not by a Fas(CD95) antagonist. (1996) (49)
Activation of B lymphocytes by monovalent anti-Lyb-2 antibodies (1984) (49)
Altered Viral Fitness of HIV‐1 Following Failure of Protease Inhibitor‐Based Therapy (2000) (48)
Extreme Genetic Divergence Is Required for Coreceptor Switching in HIV-1 Subtype C (2011) (48)
Deletion of nef slows but does not prevent CD4-positive T-cell depletion in human immunodeficiency virus type 1-infected human-PBL-SCID mice (1997) (46)
Hepatitis C (HCV) genotype and viral titer distribution among Argentinean hemophilic patients in the presence or absence of human immunodeficiency virus (HIV) co‐infection (1997) (46)
Lyb Antigens and their Role in B Lymphocyte Activation (1983) (45)
Cloning and characterization of functional subtype A HIV-1 envelope variants transmitted through breastfeeding. (2007) (44)
Evolution of CCR5 Use before and during Coreceptor Switching (2008) (44)
Transfer of human chronic lymphocytic leukemia to mice with severe combined immune deficiency. (1992) (43)
EBV-associated B-cell lymphomas following transfer of human peripheral blood lymphocytes to mice with severe combined immune deficiency. (1990) (42)
Viral pathogenesis in hu-PBL-SCID mice. (1996) (42)
Induction of B cell priming by neonatal injection of mice with thymic-independent (type 2) antigens. (1978) (42)
Virus Entry via the Alternative Coreceptors CCR3 and FPRL1 Differs by Human Immunodeficiency Virus Type 1 Subtype (2009) (41)
CD4+ T cells from IRF-1-deficient mice exhibit altered patterns of cytokine expression and cell subset homeostasis. (1997) (41)
Resistance to the CCR5 Inhibitor 5P12-RANTES Requires a Difficult Evolution from CCR5 to CXCR4 Coreceptor Use (2011) (39)
Epstein-Barr virus nuclear protein 2 is a critical determinant for tumor growth in SCID mice and for transformation in vitro (1992) (39)
Cloned human CD8+ cytotoxic T lymphocytes protect human peripheral blood leukocyte-severe combined immunodeficient mice from HIV-1 infection by an HLA-unrestricted mechanism. (1994) (39)
Ontogeny of mouse T-lymphocyte function. (1975) (38)
Chemokine receptor CCR5 genotype influences the kinetics of human immunodeficiency virus type 1 infection in human PBL-SCID mice (1997) (37)
Human immunodeficiency virus infection of human cells transplanted to severe combined immunodeficient mice. (1996) (36)
Specific H chain junctional diversity may be required for non-T15 antibodies to bind phosphorylcholine. (1988) (35)
Early modifications of host cell gene expression induced by HIV‐1 (1998) (35)
Separation of macrophages on plastic and glass surfaces. (1984) (35)
Conserved Changes in Envelope Function during Human Immunodeficiency Virus Type 1 Coreceptor Switching (2007) (35)
EBV-induced human B cell lymphomas in hu-PBL-SCID mice. (1992) (34)
High prevalence of infection with a single hepatitis C virus genotype in a small rural community of Argentina (2006) (31)
The Cell Tropism of Human Immunodeficiency Virus Type 1 Determines the Kinetics of Plasma Viremia in SCID Mice Reconstituted with Human Peripheral Blood Leukocytes (1998) (30)
The immunoglobulin allotype contributed by peritoneal cavity B cells dominates in SCID mice reconstituted with allotype-disparate mixtures of splenic and peritoneal cavity B cells (1990) (30)
Adoptive transfer of neonatal T lymphocytes rescues immunoglobulin production in mice with severe combined immune deficiency (1991) (30)
Induction of CD44 expression by the epstein‐barr virus latent membrane protein LMP1 is associated with lymphoma dissemination (1995) (27)
Immunological disease induced by injecting F1 lymphoid cells into certain parental strains. (1974) (27)
Epstein-Barr virus-induced human B-cell lymphomas in SCID mice reconstituted with human peripheral blood leukocytes. (1992) (26)
Human xenograft models for virus infection. (2000) (24)
The envelope gp120 gene of human immunodeficiency virus type 1 determines the rate of CD4-positive T-cell depletion in SCID mice engrafted with human peripheral blood leukocytes (1996) (21)
Virus and target cell evolution in human immunodeficiency virus type 1 infection (2000) (21)
Variations in the Biomechanical Properties of Articular Cartilage of the Midcarpal Joint of Normal Horses (1995) (20)
Evolution of CXCR4-Using Human Immunodeficiency Virus Type 1 SF162 Is Associated with Two Unique Envelope Mutations (2007) (20)
B Lymphocyte Development and Activation: Analysis with a Mutant Mouse Strain (1979) (19)
Immunologic effects of neonatal infection with mouse thymic virus. (1975) (19)
The Cell Tropism of Human Immunodeficiency Virus Type 1 Determines the Kinetics of Plasma Viremia in SCID Mice Reconstituted with Human Peripheral Blood Leukocytes (1998) (18)
Immunodeficient mice xenografted with human lymphoid cells: New models forin vivo studies of human immunobiology and infectious diseases (1990) (18)
Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Gag- and Gag Peptide-Specific CD4+ T-Cell Clones from an HIV-1-Seronegative Donor following In Vitro Immunization (2002) (17)
Effective therapy of the LP-BM5 murine retrovirus-induced lymphoproliferative immunodeficiency disease with diethyldithiocarbamate. (1991) (17)
Lyb-8.2: A new B cell antigen defined and characterized with a monoclonal antibody (2004) (17)
Human immunodeficiency virus type 1 infection of neonatal severe combined immunodeficient mice xenografted with human cord blood cells. (1994) (17)
Epstein-Barr virus and lymphoproliferative disease. (1999) (17)
GB virus C and mortality from HIV infection. (2002) (16)
LP-BM5 murine retrovirus-induced immunodeficiency disease in allogeneic SCID chimeric mice. Inability to recognize a putative viral superantigen does not prevent induction of disease. (1993) (16)
“Resistance” to PSC-RANTES Revisited: Two Mutations in Human Immunodeficiency Virus Type 1 HIV-1SF162 or Simian-Human Immunodeficiency Virus SHIVSF162-p3 Do Not Confer Resistance (2010) (16)
Evaluation of gp160 vaccinees in the hu-PBL-SCID mouse model. (1992) (16)
Cellular requirements for antigen presentation in the induction of a thymus-independent antibody response in vitro. (1980) (16)
Induction and Rapid Expression of an Immune Response in vitro (1968) (15)
CCR5 Mutations Distinguish N-Terminal Modifications of RANTES (CCL5) with Agonist versus Antagonist Activity (2012) (15)
Small animal models for acquired immune deficiency syndrome (AIDS) research. (1996) (15)
Immunobiology of Epstein-Barr virus-associated lymphomas. (1994) (14)
Adhesion and fusion efficiencies of human immunodeficiency virus type 1 (HIV-1) surface proteins (2013) (14)
CD4+CD8- thymocytes from neonatal mice induce IgM production in SCID mice. (1992) (14)
Type I consensus IFN (IFN-con1) gene transfer into KSHV/HHV-8-infected BCBL-1 cells causes inhibition of viral lytic cycle activation via induction of apoptosis and abrogates tumorigenicity in sCID mice. (1999) (12)
The effect of different bovine viral diarrhea virus genotypes and biotypes on the metabolic activity and activation status of bovine peripheral blood mononuclear cells. (1998) (12)
T cell activation of antigen-specific antibody responses by large B cells is MHC restricted. (1986) (11)
2 – The Role of Macrophages in the Specific Determination of Immunogenicity and Tolerogenicity (1976) (11)
Ontogeny of in vitro correlates of graft-versus-host reactions. (1976) (11)
Introduction for “Safety Considerations for Retroviral Vectors: A Short Review” (2004) (11)
Cytogenetic characterization of B-cell lymphomas from severe combined immunodeficiency disease mice given injections of lymphocytes from Epstein-Barr virus-positive donors. (1992) (10)
HIV-1 envelope evolution and vaccine efficacy. (2005) (10)
Break for SCIDs (1991) (10)
Lack of pseudotype formation between human immunodeficiency virus type 1 and Epstein-Barr virus in productively coinfected B lymphoblastoid cell lines. (1995) (10)
Circulating human CD4 and CD8 T cells do not have large intracellular pools of CCR5. (2011) (10)
SEPARATION OF MURINE MACROPHAGES BY ADHERENCE TO SOLID SUBSTRATES (1981) (10)
Introduction: Humanizing the mouse (1996) (9)
Consequences of secondary or co-infections for immunity. (1994) (8)
Interaction of helper T cells and Lyb5+ B cells responding to phosphorylcholine is MHC-restricted (1984) (8)
Ontogeny of Mouse Lymphocyte Function (1974) (8)
ACTIVATION OF AND TOLERANCE INDUCTION IN DNP-SPECIFIC B CELLS: ANALYSIS WITH THREE DISTINCT DNP-CARRIER CONJUGATES (1974) (8)
Cell cooperation during in vivo anti‐hapten antibody responses: VI. Evidence for an allogeneic effect replacing one of two helper T cells (1980) (8)
High anti-TNP plaque-forming cell potential of residual mIg+ cells in a T cell population. (1980) (8)
Maturation of reactivity to histocompatibility antigens. (1972) (7)
Distinct rates and patterns of human CD4+ t-cell depletion in hu-PBL-SCID mice infected with different isolates of the human immunodeficiency virus (1995) (6)
Low doses of DNP-D-GL, a potent hapten-specific tolerogen, are immunogenic in vitro (1975) (6)
Helper T lymphocytes from xid and normal mice support anti-phosphocholine antibody responses with equivalent T15, 511, and 603 idiotypic composition. (1984) (5)
Are xid B lymphocytes representative of any normal B cell population. A commentary. (1985) (5)
Respond to phosphorylcholine on immunogenic carriers. (1977) (5)
Enhanced tumorigenicity of an Epstein-Barr virus-transformed lymphoblastoid cell line is associated with a unique 1:18 chromosomal translocation and decreased expression of lymphocyte function associated antigen-1a (CD11A). (1993) (5)
Elements of the Human Immune System: Studies of Mature Lymphoid Cells Following Xenotransplantation to Scid Mice (1989) (5)
B lymphocyte development, heterogeneity, and function. (1978) (5)
Specific loss of stimulator activity following mixed lymphocyte reactions is due to cytotoxic cells (1976) (5)
Biological activity of diethyldithiocarbamate (Ditiocarb, Imuthiol) in an animal model of retrovirus-induced immunodeficiency disease and in clinical trials in patients with HIV infection. The Ditiocarb Study Group. (1990) (5)
Dose response and timing effects in the therapy of the LP-BM5 murine retrovirus-induced lymphoproliferative immunodeficiency disease with diethyldithiocarbamate. (1993) (5)
Modeling AIDS in a mouse. (1996) (4)
Evaluation of protective immunity to HIV-1 in human PBL-SCID mice. (1996) (4)
Distinct rate and patterns of human CD4+ T-cell depletion in hu-PBL-SCID mice infected with different isolates of the human immunodeficiency virus. (1995) (4)
THE ROLE OF ANTIGEN PRESENTATION IN B CELL ACTIVATION: ANALYSIS WITH TWO DNP-POLYMER CONJUGATES (1975) (4)
VH11 bias and normal V-D-J junctions in SCID B lymphocytes rescued by neonatal T cell transfer. (1994) (3)
Transient appearance of PHA-reactive thymocytes in the foetal mouse. (1973) (3)
Ontogeny of susceptibility of mouse splenic B cells to tolerance induction in vitro by TNP‐D‐GL (1979) (3)
High-Sequence Diversity and Rapid Virus Turnover Contribute to Higher Rates of Coreceptor Switching in Treatment-Experienced Subjects with HIV-1 Viremia. (2016) (3)
Discussion The Proliferation of Antibody-Forming Cells (1969) (3)
Idiotype Regulation in the Antibody Response to Phosphocholine (1984) (3)
Reactivity of steroid-resistant neonatal thymocytes (1974) (3)
Circulating human CD 4 and CD 8 T cells do not have large intracellular pools of CCR 5 (2011) (3)
DERIVATION AND CHARACTERISTICS OF THE CBA/N SUBLINE (1978) (2)
Synergizing Helper T Cell Sets and the Regulation of Antibody Quality (1980) (2)
Resistance to the CCR 5 inhibitor 5 P 12-RANTES requires a difficult evolution from CCR 5 to CXCR 4 coreceptor use (2017) (2)
The Story Behind “A Requirement for Two Cell Types for Antibody Formation in vitro” (2014) (1)
IS LYB 2, A B-LYMPHOCYTE SURFACE ANTIGEN, A TARGET FOR A T CELL-DERIVED FACTOR? (1982) (1)
CD4 T Cell Depletion in hu-PBL-SCID Mice by Noncytopathic HIV Isolates (1993) (1)
Immunological effects of neonatal infection with mouse thymic virus, a herpesvirus of mice. Abstr. (1975) (1)
Changes in HIV-1 tropism: clinical and prognostic consequences. (2007) (1)
Does preferential Th subset activation contribute to the murine acquired immunodeficiency disease (MAIDS)? (1994) (1)
Inhibitors that target gp120 interactions with coreceptor (2007) (1)
The human immunodeficiency virus: Biology, immunology and theraphy (2003) (1)
MONOCLONAL LYMPHOID POPULATIONS AND THEIR PRODUCTS (1982) (0)
Animal Models for HIV Infection: Hu-PBL-SCID Mice (1999) (0)
Conserved Changes in Envelope Function during Human Immunodeﬁciency Virus Type 1 Coreceptor Switching (cid:1) (2007) (0)
Response: absence of CCR5 intracellular pools in most CD4 and CD8 T cells (2011) (0)
Activation of a b lymphocyte subset by monoclonal anti-lyb 2 antibodies. Abstr. (1983) (0)
Epstein-Barr Virus-induced Human B-Cell Lymphomas in SCID Mice Reconstituted with Human Peripheral Blood Leukocytes1 (2006) (0)
RAPID CD4 T CELL DEPLETION IN HUMAN-PBL-SCID MICE BY NON-CYTOPATHIC MACROPHAGE-TROPIC ISOLATES OF HIV (2018) (0)
MINIREVIEW Human Xenograft Models for Virus Infection (2000) (0)
Rationale for testing chemokine inhibitors (Virustats) for prevention of HIV-1 transmission. (2001) (0)
Virus Entry via the Alternative Coreceptors CCR3 and FPRL1 Differs by Human Immunodeﬁciency Virus Type 1 Subtype (cid:1) † (2009) (0)
Regulation of the response to phosphorylcholine in balb/c mice. Abstr. (1978) (0)
Primary Examiner-Alvin Oberley 11 Patent Number : 4 , 952 , 921 45 Date of Patent : Aug . 28 , 1990 (2017) (0)
Certain parental strains. (1974) (0)
, by N-Terminal Modifications of RANTES Immunodeficiency Virus Type 1 Inhibition Two Mechanisms for Human (2003) (0)
Susceptibility of mouse neonatal splenic b cells to tolerance induction in vitro with tnp-d-gl. Abstr. (1977) (0)
The InmmunoglobulinAllotypeContributedby Peritoneal CavityB CellsDominatesinSCID Mice Reconstituted withAllotype-disparate Mixturesof Splenicand Peritoneal CavityB Cells (1990) (0)
MONOCLONAL ANTIBODIES AGAINST HUMAN B CELLS (1982) (0)
Scaling Up Digital Circuit Computation with DNA Strand Displacement Cascades (2011) (0)
For our Colleagues and Friends in Japan (2011) (0)
Regulation of anti-phosphocholine antibody responses in athymic nu/nu mice. (1982) (0)
Mice with the xid defect can provide t help for a t15 dominant igm anti-phosphocholine response. Abstr. (1983) (0)
The activity of a potent neutralizing human antibody against primary isolates in vivo (1998) (0)
J. Virol.-2011-Jiang-10669-81 (2012) (0)
HIV results in the frame. CD4+ cell turnover. (1995) (0)
HIV-1 Strain-dependent CD4 T Cell Depletion in hu-PBL-SCID Mice (1993) (0)
Preliminary evidence for a new non-H-2 locus that codes for lymphocyte-activating determinants distinct from Mls. (1979) (0)
Ontogeny of t lymphocyte function, early appearance and subsequent loss of fetal mouse thymocyte reactivity. Abstr. (1973) (0)
Lymphocyte-activating determinants distinct from mls. (1979) (0)
Reply to Schuitemaker and Miedema (1995) (0)
Role for lyb5 determinants in b lymphocyte triggering. Abstr. (1978) (0)
Epstein-Barr Virus-induced Human B-Cell Lymphomas in SCID Mice Reconstituted with Human Peripheral Blood Leukocytes 1 (2006) (0)
B lymphocytes in the immune response : proceedings of the International Conference on B Lymphocytes......,Scottsdale, Ariz., 1978 (1979) (0)
Epstein-Barr VirusNuclear Protein 2IsaCritical Determinant for TumorGrowthinSCIDMiceandforTransformation InVitro (1992) (0)
Viruses that Affect the Immune System. Papers Presented at a Conference Held in Newport Beach, California, March 1990.Hung Y. Fan , Irvin S. Y. Chen, Naomi Rosenberg , William Sugden (1992) (0)
, Vectors Long-Term Engraftment of NOD / SCID Mice by HIV Cells That Mediate + Transduction of Human (2009) (0)
Fifth International Conference on AIDS : the Scientific and Social Challenge; specialty session transcript; animal models, part 1 (1989) (0)
CCR5 sequestration by RANTES analogues: a rational and plausible strategy for topical prevention of HIV infection. (2006) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Donald E. Mosier?

Donald E. Mosier is affiliated with the following schools: